The mandate also calls for the Department of Health and Human Services to negotiate lower prices across all markets....
US prices across all drugs — both brand name and generics — were nearly 2.78 times as high as those in comparable countries in 2022, according to an HHS report last year....
For brand drugs, the US prices were at least 3.22 times as high, even after adjusting for estimated rebates. This story has been updated with additional information....
综合
美国有线电视-特朗普新闻
2025-05-12 00:00:00.0
